As stewards of the planet, we’re always trying to find ways to reduce our corporate carbon footprint and offset the environmental damage done through research. Operating a lab requires a lot of electricity: powering the freezers, microscopes, autostainers, and so much more. It all adds up. If you’re like us, you also want to find a way to give back, beyond the good that your research provides.
If one were asked to describe a Cell Signaling Technology (CST) antibody sampler kit, we would totally understand an answer like, “it’s an assortment of antibodies.” Honestly, on its face, that answer isn’t exactly wrong. It just makes the process seem a little random. Especially considering the reality:
We’re honored to win two CiteAb awards in 2020: Antibody Supplier of the Decade and Antibody Supplier Succeeding in Alzheimer’s Research. CST was also highly commended as an ELISA Kit Supplier to Watch in 2020. It’s always nice to be recognized for your work. In this case, it’s especially sweet because both efforts are near and dear to our hearts.
Topics: Antibody Performance
Antibodies are essential reagents that support all levels of scientific research. Used in a multitude of applications to identify, quantify, and isolate specific target biomolecules, they have recently become the focus of intense scrutiny for their contribution to the ongoing reproducibility crisis.
The start of a new year is always a crazy time. There’s plenty to look back on and celebrate, things to anticipate, and of course there are opportunities for improvement. What do we look forward to in 2020? We’re about to celebrate our 5th blog anniversary! It’s hard to believe that Lab Expectations is five years old.
Topics: Science Education
Western blotting is used to detect proteins and analyze their expression using antibodies, but it does have its limitations. Flow cytometry also employs antibodies, but it uses fluorescence to detect and analyze protein expression on a cell-by-cell basis.
Understanding the microenvironment of disease is critical for the success of targeted therapies. For years, the complex landscape of the tumor microenvironment could only be studied in single-cell snapshots by flow cytometry or limited tissue staining. Advanced multiplexing technologies such as Imaging Mass Cytometry™ (IMC™) now enable the imaging of up to 40 protein markers on both the cellular and tissue level.
Have you ever wondered about the minds behind our antibodies? We talk a lot about validation, specificity, sensitivity, and reproducibility. All of that is very important, but that doesn't tell you much about who developed it.
If you haven’t heard already, it’s CST’s 20th anniversary. Woohoo! You could say this year is kind of a big deal for us. We have a lot to celebrate. However, once we started listing the successes over the years, we realized that we are most proud of what you – the researchers worldwide – have accomplished using our reagents. After all, we don’t live in a vacuum. We exist to serve you and enable important discoveries and the development of cures.
Today marks 20 years of impact in scientific research and community support. We haven't done this alone — you’ve inspired us to think bigger and tackle greater challenges— we’ve Created Something Together. Thank you for standing with us.
Topics: Corporate Social Responsibility